Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 7,500 shares at $29.01 ($218K) on 2017-02-22, disclosed to the SEC on 2017-02-23.
Open-market sale of $218k NXTM by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-03-22 | $83K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |